Literature DB >> 3136235

Sequelae of the osmotic blood-brain barrier opening in rats.

M Suzuki1, Y Iwasaki, T Yamamoto, H Konno, H Kudo.   

Abstract

Histopathological sequelae of the osmotic blood-brain barrier opening were studied in 69 adult Wistar rats sacrificed between 2 minutes and 6 days after infusion of 1.6 M mannitol into the unilateral internal carotid artery. The results were correlated with immunohistochemical localization of autologous albumin in the brain parenchyma on paraffin sections. Extravasation of serum albumin was evident in all rats, and the albumin immunoreactivity, commonly localized to the territories of the ipsilateral anterior, middle, and posterior cerebral arteries and contralateral anterior cerebral artery, showed maximum intensity in the rats sacrificed 30 minutes after infusion. The albumin immunoreactivity remained macroscopically visible in the brain parenchyma for 24 to 48 hours, and then gradually faded out. Serum extravasation was accompanied by widening of the perivascular space and focal edema, which largely subsided within 48 hours as the albumin immunoreactivity of the tissue diminished. Although no overt neurological sequelae were seen in the present experiment, minute but definite foci of infarction with focal accumulation of albumin were found in 23 (38%) of 61 rats surviving more than 30 minutes. In addition, ischemic neuronal death of delayed onset was encountered among neurons in the CA-1 region of the hippocampus, in the cerebellum, and in the thalamus in five (25%) of 20 rats sacrificed between Days 4 and 6. Thus, care should be exercised in the practice of this procedure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136235     DOI: 10.3171/jns.1988.69.3.0421

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

Review 1.  Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.

Authors:  S I Rapoport
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  Mechanisms of blood-brain barrier breakdown.

Authors:  J Greenwood
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

3.  Astrocytes are an early target in osmotic demyelination syndrome.

Authors:  Fabrice Gankam Kengne; Charles Nicaise; Alain Soupart; Alain Boom; Johan Schiettecatte; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

Review 4.  Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system.

Authors:  J B Van Bree; A G De Boer; M Danhof; D D Breimer
Journal:  Pharm World Sci       Date:  1993-02-19

5.  Targeting of adoptively transferred experimental allergic encephalitis lesion at the sites of wallerian degeneration.

Authors:  H Konno; T Yamamoto; H Suzuki; H Yamamoto; Y Iwasaki; Y Ohara; H Terunuma; N Harata
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 6.  Pharmacologic Control of Blood Pressure in Infants and Children.

Authors:  Joseph D Tobias; Aymen Naguib; Janet Simsic; Catherine D Krawczeski
Journal:  Pediatr Cardiol       Date:  2020-09-11       Impact factor: 1.655

7.  Distribution of extravasated serum protein after cryoinjury in neonatal and adult rat brains.

Authors:  M Suzuki; Y Iwasaki; K Umezawa; O Motohashi; N Shida
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Evidence for early blood-brain barrier breakdown in experimental thiamine deficiency in the mouse.

Authors:  N Harata; Y Iwasaki
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584

9.  Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors.

Authors:  Y Iwadate; H Namba; T Saegusa; K Sueyoshi
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

Review 10.  Liposomes and nanotechnology in drug development: focus on neurological targets.

Authors:  Pedro Ramos-Cabrer; Francisco Campos
Journal:  Int J Nanomedicine       Date:  2013-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.